We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SUN:NYSESunoco LP Analysis

Data as of 2026-06-13 - not real-time

$65.32

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Sunoco LP trades at $65.32, comfortably above its 200‑day SMA of $58.5 but below the 20‑day ($67.5) and 50‑day ($66.9) averages, indicating short‑term weakness within a longer‑term uptrend. Valuation metrics are attractive: a trailing P/E of 16.7 is well under the industry average of 21.5 and the price‑to‑book of 1.37 suggests the stock is undervalued. The dividend yield of 5.74% is compelling, yet a payout ratio near 93% and free cash flow that falls short of the annual dividend raise sustainability concerns.
The balance sheet is heavily leveraged, with a debt‑to‑equity ratio of 185, and the company’s volatility sits at 31% over the past month, flagging heightened price swings. Recent earnings showed an EPS beat (2.85 vs. expectations) but revenue missed, and the stock slipped 2% pre‑market. Technical indicators are mixed – RSI at 45 signals neutral momentum, while a bearish MACD and decreasing volume suggest caution. Overall, Sunoco offers a value‑oriented play with a strong dividend, but investors must weigh the debt burden, volatility, and dividend sustainability before committing.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above the $63.76 support level
  • Bearish MACD and decreasing volume signal limited upside
  • Dividend payout ratio approaching unsustainable levels

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Valuation discount relative to industry peers
  • Attractive 5.74% dividend yield if cash flow improves
  • Potential upside toward the $72.88 resistance level

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt‑to‑equity ratio may constrain future growth
  • Energy sector regulatory and transition risks
  • Sustained dividend income contingent on cash‑flow stability

Key Metrics & Analysis

Financial Health

Revenue Growth106.40%
Profit Margin3.14%
P/E Ratio16.7
ROE15.42%
ROA4.39%
Debt/Equity184.68
P/B Ratio1.4
Op. Cash Flow$1.5B
Free Cash Flow$115.9M
Industry P/E21.5

Technical Analysis

TrendBullish
RSI45.0
Support$63.76
Resistance$72.88
MA 20$67.50
MA 50$66.89
MA 200$58.51
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Target Price$74.13
Upside/Downside13.48%
GradeUndervalued
TypeValue
Dividend Yield5.74%

Risk Assessment

Beta-0.12
Volatility31.27%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.